A component of VLDL, chylomicrons, and HDL which inhibits lipoprotein lipase activation by displacing Apo CII. Elevated Apo CIII levels correlate with increased cardiovascular risk and type 2 diabetes.
Specifications
- Denotes B2B Option Only:
- 16-16-120303-5x100UG
- Purity:
- ≥95% (SDS-PAGE)
- Source Material:
- Human Plasma
- MW (Molecular Weight):
- 8.75 kDa
- Form:
- Frozen
- Buffer:
- 10 mM NH4HCO3, pH 7.4
- Protein Determination:
- Modified Lowry
- UniProt ID:
- P02656
- Gene ID:
- APOC3, 345
- Storage Temperature:
- ≤ -70°C
- Shipped On:
- Dry Ice
- Standard Grade:
- Yes
- Low Endotoxin Grade (LEL) Link:
- 16-16-120303-LEL
- Grade:
- Standard Grade
- Product Type:
- Transport & Binding Proteins, Glycoproteins & Acute Phase Proteins
- Research Area:
- Cardiovascular, Metabolism & Endocrinology
- Application:
- In Vitro Diagnostics (IVD), Antibody & Antisera Production
